Radiofrequency thermocoagulation (RF-TC) is “a safe, minimally invasive treatment option for patients with refractory focal epilepsy,” specialists have concluded.
At AES 2018, the researchers from Emory University School of Medicine, in Atlanta, Georgia, USA, reported outcomes in a series of 15 patients who underwent the procedure at the center over a 3-year period.
In RF-TC, intracranial EEG electrodes are used to create small lesions, potentially allowing patients to avoid the need for larger-scale traditional destructive surgery.
The 15 patients were selected for RF-TC either because of the location of the seizure focus in eloquent cortex (6 patients), or as a preliminary treatment to potentially avoid future surgery (a “test ablation” procedure; 9 patients).
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.